Switzerland offers non-mRNA Covid-19 vaccine alternative
The Swiss government has signed a contract with the American firm Janssen, part of the Johnson & Johnson group of companies, to purchase 150,000 doses of its Covid-19 vaccine, a viral vector model delivered in only one shot.
Cantons, which are responsible for organising vaccinations, are set to receive the vaccine early next week and will be able to offer the jab primarily to people who cannot be given the mRNA vaccine for medical reasons.
The vaccine was approved for use by medicine regulator Swissmedic in March. Until now the country had been offering two different vaccines in two doses to its population developed by Moderna and by Pfizer/BioNTech. These vaccines use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
By contrast, the Janssen vaccine can be administered in one shot and is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
According to the authorities, the vaccine offers “very good protection” against hospitalisation and severe forms of the illness. Johnson & Johnson have said that recent research shows the vaccine is even more effective when administered twice.
Not recommended for pregnant women
Christoph Berger, president of the Federal Vaccination Commission, told reporters in Bern that a very small minority — less than 100 people — may have an intolerance, such as a severe allergic reaction, to the mRNA vaccines.
The Commission and the federal public health office do not recommend the Janssen vaccine for pregnant women and people with immune deficiencies, who instead are advised to take the mRNA vaccines. The mRNA vaccines are also recommended for children aged 12 and older.
Berger said the Janssen vaccine is an alternative for people who are sceptical of mRNA shots. Compared to other European countries, vaccination uptake is relatively low in Switzerland, with around 58% of the population fully jabbed. A survey conducted in July by the research group Sotomo and reported by the SonntagsZeitung newspaper showed that most of the unvaccinated (72%) were holding out due to fears about mRNA technology.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Many Swiss could prefer wider vaccine choice, survey finds
This content was published on
The representative survey by research group Sotomo, reported in the SonntagsZeitung, was carried out in July, well before the introduction of the Covid certificate obligation this week. However, according to experts interviewed by the paper, it could be a sign that Switzerland’s vaccination campaign would be boosted by making available other jabs which don’t use…
This content was published on
Switzerland plans to boost its Covid-19 vaccination campaign over the summer with the aim to reach 80% of the population.
Health office advocates vaccine three months after Covid recovery
This content was published on
People who catch Covid-19 should get vaccinated three months after recovering and not six months, says the Swiss health office.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.